Skip to main content
. 2014 Mar 28;24(4):360–370. doi: 10.1111/bpa.12131

Figure 2.

figure

Cripto‐1 ( CR ‐1) in glioma patient blood and its association with overall survival of the patients. A. CR‐1 protein in glioblastoma multiforme (GBM) plasma samples, normal control plasma and plasma of lower grade glioma patient. Normalization is performed relative to the total protein contents of each sample. B. Kaplan–Meier plot showing overall survival in glioblastoma and low‐grade glioma patients by plasma levels of CR‐1 above or below the average control level set at 0.60 ng/mL. Symbols on the line indicate patients alive at the time of analysis.